innate-like lymphocytes ͉ T cell development ͉ transgenics
P eripheral CD4
ϩ and CD8 ϩ T cell subsets have been traditionally divided into naïve CD44 lo CD62L ϩ and memory CD44 hi CD62L Ϫ populations, while the surface expression phenotype of the latter population also resembles recently activated T cells (1, 2) . In recent years it became clear that the memory T cell subset is not a population consisting only of true antigenspecific memory cells that developed in response to a foreign antigen. Rather, the memory population contains a variety of different T lymphocyte subsets: some may have acquired their memory marker phenotype through homeostatic proliferation, whereas others show immediate effector function and may play a role in the front-line defense against certain bacterial infections. These additional cells were described as memory phenotype (MP) T lymphocytes, and some subsets of the MP population are also described as innate T cells (3, 4) . Certain MP or innate-like T cells are derived from double-positive (DP) thymocytes, and at least some of these cells can be selected on non-classical MHC class Ib molecules (5) , achieved by interaction with hematopoietic cells rather than with thymic epithelial cells (6) . Among the innate-like T lymphocyte subsets that have been characterized are natural killer T cells (NKT cells) (7) (8) (9) , H2-M3 specific T cells (10) , mucosal-associated invariant T cells (11) , and also CD8␣␣ expressing intraepithelial lymphocytes of the gut (12) .
Important insight about signaling molecules that are involved in conventional versus innate-like T cell differentiation is provided from studies on Tec family kinase-deficient mice (4) . IL2-inducible T-cell kinase (Itk) and resting lymphocyte kinase (Rlk) are essential for the development of conventional CD8 ϩ T cells. As a consequence, ItkϪ/Ϫ mice and ItkϪ/ϪRlkϪ/Ϫ mice are almost devoid of conventional CD8 ϩ T cells, whereas the remaining CD8
ϩ T cell subsets have several characteristics of innate-like T lymphocytes (13) (14) (15) (16) . Conventional CD4 ϩ T cells are also reduced in the absence of Itk; thus, ItkϪ/Ϫ mice have also a relative increase in innate-like MP CD4 ϩ T cells (17) . In addition, ItkϪ/Ϫ mice have reduced numbers of NKT cells (18) (19) (20) . Another important signaling cascade that has been shown to differentially influence conventional and innate-like MP T lymphocyte development involves the signaling lymphocyte activation molecule and signaling lymphocyte activation molecule-associated protein (21) (22) (23) (24) .
To gain more insight into the function of Itk in T cells, Affymetrix microarray experiments were performed to identify genes that are differentially expressed between WT and ItkϪ/Ϫ T cells (K.E.M.B., unpublished work). One of the genes identified that was up-regulated in ItkϪ/Ϫ CD3 ϩ T cells was Zbtb16, which encodes for the transcriptional repressor promyelocytic leukemia zinc finger (PLZF). PLZF regulates several biological processes and has also been implicated in tumorigenesis (25) . PLZF belongs to the family of BTB (bric-a-brac, tramtrack, broad complex) domain-containing zinc finger factors (BTB-ZF) (25, 26) , and important functions in the T cell lineage have been described for several members of the BTB-ZF gene family (27) .
In this study we investigated the role of PLZF in T cells. We show that PLZF was expressed in the CD4 ϩ CD44 hi T cell lineage but not in the naïve CD4 ϩ CD44 lo subset, whereas CD8 ϩ T cells did not express detectable levels of PLZF. Enforced transgenic expression of PLZF in T lymphocytes induced a T cell intrinsic program leading to an increase in CD44 hi MP T cells and a corresponding decrease of naïve CD44 lo T cells. The CD44 hi population produced IFN␥ upon PMA/ionomycin stimulation, thus sharing characteristics with innate T lymphocytes. Transgenic CD4 ϩ T cells showed enhanced IL-4 levels after anti-CD3/ CD28 stimulation and an increase in a CD44 hi CD62L
ϩ IL-4-producing subset. Together, our data indicate that PLZF is a novel transcriptional regulator for the development of CD44 hi MP T cells with innate-like features.
Results
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that are differentially expressed between WT and ItkϪ/Ϫ CD3 ϩ T lymphocytes during T cell activation (K.E.M.B., unpublished work). One gene identified that was already expressed at higher levels in unstimulated Itk-deficient CD3 ϩ T cells compared with WT cells was Zbtb16, which encodes for the transcriptional regulator PLZF. Immunoblot analysis confirmed the upregulation of PLZF in ItkϪ/Ϫ T cells (Fig. 1A) . Because T cell subsets in ItkϪ/Ϫ mice have a T cell memory phenotype (13-17), we investigated whether the increase in the expression of PLZF was caused by a higher percentage of MP T cells in ItkϪ/Ϫ mice. Therefore, WT CD4 ϩ and CD8 ϩ T cell subsets were sorted into CD62L ϩ and CD62L Ϫ fractions. Immunoblot analysis of these sorted subsets revealed that PLZF was expressed in the WT CD4 ϩ CD62L Ϫ T cell population but in neither CD4 ϩ CD62L ϩ nor CD8 ϩ T cells (Fig. 1 A) . (Fig. 1B) . In addition, low-level expression of Zbtb16 was observed in CD44 hi CD62L ϩ cells, in contrast to CD44 lo CD62L ϩ cells (Fig.  1B) . Together, this set of data indicated a correlation between PLZF expression and the CD44 hi MP CD4 ϩ T cell subset. To investigate a potential role of PLZF in the generation and/or function of the CD4 ϩ CD44 hi T cell subset, gain-of-function experiments were performed. Therefore, transgenic mice expressing PLZF under the control of Cd4 cis-regulatory element were generated (Fig. 1C) , which direct expression from the DN3 stage on, and remain active in, CD4
ϩ and CD8 ϩ T cell subsets (data not shown). Further, the transgenic expression vector contained an IRES-GFP cassette to detect transgenic T cells by GFP expression. Three different founder lines (lines 1, 2, and 3) were selected for further studies. In thymocytes, PLZF was expressed at higher levels in line 2 compared with line 1, correlating with GFP levels [supporting information (SI) Fig.  S1 ]. Furthermore, transgenic peripheral CD4 ϩ T cells showed high levels of PLZF protein compared with W T MP CD4 ϩ CD62L Ϫ T cells, although PLZF levels were only slightly enhanced in line 2 compared with line 1 (Fig. S1 ).
Transgenic Expression of PLZF Induces Dose-Dependent Changes in
CD44 and CD62L Expression on Peripheral T Cells. PLZF transgenic mice displayed a moderate alteration in peripheral T cell numbers and had increased CD4/CD8 ratios ( Fig. S2 A and B) . Because the PLZF expression pattern suggested a specific function of PLZF in the CD44 hi T cell subset, the CD44 versus CD62L expression pattern on peripheral splenic and LN T cells was determined in PLZF transgenic mice. This analysis revealed a decrease in the CD44 lo CD62L ϩ naïve CD4 ϩ and CD8 ϩ T cell subset and a corresponding increase of the CD44 hi CD62L
Ϫ population in the presence of PLZF ( Fig. 2A and Fig. S3 ). We also noted an increase in the CD44 lo CD62L Ϫ population in PLZF transgenic mice compared with WT mice. Furthermore, the percentage of CD44 hi CD62L ϩ as well as CD44 hi CD62L
Ϫ cells increased with increasing levels of PLZF expression, indicating a dose-dependent effect of PLZF ( Transgenic males of this line transmitted the mutation exclusively to their female offspring. Furthermore, almost all T cells of male mice of line 3 carrying the PLZF transgene were GFP ϩ (data not shown), whereas in hemizygous female mice of line 3, approximately only half of the T cells were GFP ϩ (Fig. 2C) . Because there were similar numbers of GFP ϩ and GFP Ϫ T cells in female transgenic mice, we concluded that PLZF-expressing T cells have no major developmental advantage or disadvantage over non-transgenic T cells. Similar to transgenic lines 1 and 2, GFP ϩ CD4 ϩ and CD8 ϩ T cells in male and female mice of line 3 displayed the altered CD44/CD62L expression pattern in the spleen (Fig. 2C and data not shown), whereas the GFP Ϫ population in female transgenic mice showed a CD44/CD62L distribution similar to WT mice (Fig. 2C) . Thus, PLZF induces a T cell-intrinsic genetic program in both CD4 ϩ and CD8 ϩ T cells that leads to a dramatic alteration in the CD44/CD62L subset distribution.
CD44 hi T cells in PLZF Transgenic Mice Develop in the Thymus and Have
a Memory Phenotype with Innate-Like Characteristics. To determine whether the CD44 hi T cells emerge already in the thymus, a comprehensive analysis of thymocyte development was performed. In contrast to WT cells, transgenic PLZF thymocytes had increased percentages of SP cells and reduced numbers of DP cells (Fig. 3A and Fig. S4A ). However, the expression of CD3 and HSA on the various subsets was similar between WT and PLZF thymocytes (Fig. 3A) . Furthermore, CD4SP and CD8SP PLZF transgenic thymocytes showed a larger fraction of cells that had down-regulated CD62L expression compared with WT SP cells, and PLZF transgenic CD8SP cells displayed an increase in CD44
hi subsets (Fig. 3B) . CD122 expression was similar in WT and PLZF transgenic SP cells (Fig. 3B ). In agreement with the thymic emergence of PLZF MP T cells, T cells with an altered CD44/CD62L profile were already present in 14-day-old PLZF transgenic mice (Fig. S5) .
The CD44 hi MP T cell population of WT mice is composed of several T cell subsets (3, 4 hi fraction (Fig. 3C and Fig. S4B ). ItkϪ/Ϫ SP thymocytes, as reported previously (13, 14) , showed increased production of IFN␥ compared with WT cells. In the periphery, the percentage of IFN␥-producing CD4 ϩ T cells within the CD44 hi population was reduced in PLZF transgenic mice compared with WT controls (Fig. 3D and Fig. S4C ). In contrast, there was an increase in IFN␥-producing CD44 hi CD8 ϩ T cells. The relative percentage of PLZF transgenic IFN␥-producing CD8 ϩ T cells within the CD44 hi population was moderately increased compared with WT MP T cells, but not as high as in innate-like ItkϪ/Ϫ CD8 ϩ T cells (Fig. 3D and Fig. S4C ). Thus, despite the dramatic increase in the numbers of MP T cells in PLZF transgenic mice, the PLZF MP population had similar innatelike functions as WT MP subsets.
Many innate T lymphocytes such as NKT cells (7) and innate-like CD8 ϩ T cells in ItkϪ/Ϫ mice require IL-15 for their survival (13, 15) . IL-15 signals via the IL-15 receptor complex, which is composed of several subunits including CD122 (28) . PLZF transgenic and WT CD44 hi CD62L ϩ CD8 ϩ T cells displayed similar up-regulated CD122 expression levels, and the percentage of CD122 ϩ cells within this transgenic subset was even slightly increased compared with the WT subset (Fig. S6) . Together, these data indicate that enforced expression of PLZF leads to the development of CD44
hi MP T cells with innate-like characteristics.
Impaired NKT Cell Development in PLZF Transgenic Mice. Because NKT cells have a CD44
hi CD62L Ϫ surface expression phenotype (7), we investigated whether PLZF expression led to an increase in NKT cells. To have internal staining controls, the analysis was performed in female PLZF transgenic mice of line 3, which have both GFP ϩ and GFP Ϫ cells within the T cell subset. CD1d tetramers (CD1d-tet) loaded with the ␣GalCer analogue PBS57 were used to detect invariant NKT cells. This analysis revealed that CD1d-tet ϩ NKT cells were severely reduced in the GFP ϩ T cell subset, whereas NKT cells were readily detected within the GFP Ϫ subset (Fig. 4A and Fig. S7A ). Next, we investigated whether the peripheral reduction of NKT cells is caused by a (partial) block during thymic NKT cell development. Early CD1d-tet ϩ NKT cells are HSA hi , followed by a HSA lo stage (7, 8 (7, 8) . Our analysis revealed that the transition from stage 2 to stage 3 is impaired in PLZF transgenic mice, indicated by an increase in stage 2 and a corresponding decrease in stage 3 NKT cells (Fig. 4B and Fig.  S7B ). This suggests that enforced expression of PLZF impairs NKT cell development.
Transgenic Expression of PLZF Alters the Cytokine Profile of Naïve
(CD44 lo ) and MP (CD44 hi ) CD4 ؉ T Cells. Next we analyzed whether PLZF expression changed the cytokine production of CD4 ϩ T cells upon T cell receptor-mediated activation. Total CD4 ϩ T cells were isolated from WT or PLZF transgenic mice and stimulated with anti-CD3/CD28. IL-2 levels were severely impaired in PLZF transgenic CD4 ϩ T cells (Fig. 5A) , and PLZF transgenic CD4 ϩ T cells produced reduced amounts of IFN␥ compared with WT CD4 ϩ T cells. In contrast, they showed dramatically increased levels of IL-4 compared with WT controls (Fig. 5A) .
To investigate which subset is responsible for the dramatic increase in IL-4, CD44 lo CD62L ϩ , CD44 hi CD62L ϩ , and CD44 hi CD62L
Ϫ , WT and PLZF transgenic CD4 ϩ T cells were sorted and activated with anti-CD3/CD28. All subsets of WT and PLZF transgenic CD4 ϩ T cells produced IL-2, whereas IFN␥ was secreted by CD44 hi CD62L ϩ and CD44 hi CD62L Ϫ T cells (Fig. 5B) . However, transgenic T cells showed reduced IL-2 and IFN␥ production compared with WT cells. WT CD44
hi CD62L
Ϫ cells produced high levels of IL-4, whereas IL-4 levels in this subset of transgenic T cells were reduced (Fig. 5B ). This is in contrast to the CD44 hi CD62L ϩ subset, which showed enhanced IL-4 levels in PLZF transgenic mice. Thus, the presence of this IL-4 producing CD44 hi CD62L ϩ subset explains why total CD4 ϩ T cells produce elevated levels of IL-4. Although Tbx21 (encoding for T-bet) and Gata3 are known to be major transcription factors responsible for IFN␥ and IL-4 expression of Th1 and Th2 cells, respectively, no major difference in the expression of Tbx21 and Gata3 in the various subsets was observed (Fig. S8) .
Discussion
In this study we showed that the BTB-ZF factor PLZF is predominantly expressed in CD44 hi CD4 ϩ T cells. Enforced expression of PLZF during T cell development and in peripheral T cells led to the appearance of a large population of peripheral T cells with a CD44 hi memory phenotype that were able to produce IFN␥ upon ex vivo PMA/ionomycin stimulation. PLZF expressing (i.e., GFP ϩ ) T cells in female mice of line 3 showed an MP despite the presence of similar numbers of GFP Ϫ T cells with a naïve phenotype, thus indicating a T cell intrinsic defect. Together with the observations that the cells were not activated and that PLZF T cells showed no increased BrdU incorporation (data not shown), this also suggests that the CD44 hi T cells are not generated via homeostatic proliferation (29) . In addition, changes in the naïve versus memory-like subset distribution were already evident at the SP stage during T cell development. This indicates that the MP T cell populations in PLZF transgenic mice are at least in part derived from DP thymocytes, like other MP T cells (3, 4) . We therefore propose that PLZF induces a transcriptional program that leads to the generation of CD44 hi MP T cells that share certain features with innate-like T cells.
The observations that PLZF is up-regulated in the ItkϪ/Ϫ T cell population (which is enriched in innate-like T cells) and that PLZF expression is restricted to the CD4 ϩ CD44 hi population revealed a correlation between PLZF expression and MP CD4 ϩ T cells. A more direct link between PLZF and innate-like MP T cells is established by the CD44 hi phenotype of transgenic T cells. Thus, ectopic PLZF expression leads to an increase of those T cell subsets that express PLZF in WT cells, indicating that PLZF can convert CD4 ϩ CD44 lo subsets into CD4 ϩ CD44 hi populations. Furthermore, endogenous PLZF was expressed in transgenic CD44 hi but not CD44 lo CD4 ϩ T cells (data not shown), an expression pattern identical to the one in WT CD4 ϩ T cell subsets. This indicates that transgenic PLZF induced the differentiation of a distinct lineage of MP T cells with innate-like characteristics. Interestingly, immunoblot analysis did not reveal expression of PLZF in innate-like CD8 ϩ T cells. However, PLZF also induced the CD44 hi phenotype in CD8 ϩ T cells, suggesting that PLZF may induce similar transcriptional programs in CD4 and CD8 T cell lineages, and possibly indicating the existence of an endogenous factor that specifically directs the development of CD44 hi MP CD8
ϩ T cells. We demonstrated that CD4 ϩ and CD8
ϩ MP T cells in PLZF mice possess innate-like characteristics. The increase in IFN␥-producing transgenic CD44 hi CD8 ϩ T cells is similar to the one observed in innate-like ItkϪ/Ϫ CD8 ϩ T cells, although the percentage of IFN␥-positive cells within the CD44 hi population is higher in the absence of Itk. Further, only peripheral MP CD8 ϩ T cells and not CD8SP MP thymocytes in PLZF transgenic mice showed an increase in IFN␥-producing CD44 hi cells upon PMA/ionomycin stimulation, suggesting a further maturation of innate-like functions in the periphery. In contrast, IFN␥-producing CD44 hi cells were increased in the thymus and in the periphery in ItkϪ/Ϫ mice. These findings may indicate a different subset composition and/or differential regulation of innate-like CD8 ϩ T cells in PLZF and ItkϪ/Ϫ mice. PLZF MP CD4 ϩ T cells produced IFN␥ as well; however, the percentage of IFN␥-positive CD4 ϩ T cells within the CD44 hi population was reduced. Moreover, upon anti-CD3/CD28 activation we observed reduced cytokine production in all subsets of PLZF transgenic CD4 ϩ T cells compared with WT CD4 ϩ T cell subsets, except for the dramatic increase of IL-4 production in the CD44 hi CD62L ϩ subset. It is possible that PLZF may downmodulate the IL-2 and IFN␥ response by binding to cytokine loci and recruiting co-repressors including nuclear receptor corepressor and histone deacetylase (25) , or by repressing the expression of an important signaling molecule or transcription factor required for cytokine expression. Alternatively, but not mutually exclusively, PLZF expression may lead to a different cellular composition of peripheral CD4 ϩ T cells, even though we could not observe any altered expression of T-bet and Gata-3 in the various subsets of PLZF transgenic mice compared with WT mice. A ''candidate'' innate-like population are NKT cells that share a CD44 hi expression phenotype with PLZF transgenic T cells (7) (8) (9) . A recent study has shown that PLZF is primarily expressed in CD1d-restricted NKT cells (30) . However, other MP T cell subsets may express PLZF as well, as PLZF expression was up-regulated in ItkϪ/Ϫ T cells, which have diminished numbers of NKT cell subsets compared with WT T cells (19, 20) . Remarkably, NKT cell numbers in mice lacking PLZF were severely reduced, and they also displayed impaired cytokine expression patterns (30) . Unexpected given this essential role of PLZF for NKT cell development, we observed a severe reduction of NKT cells in PLZF expressing mice compared with WT mice. One explanation, that both PLZF-deficient and PLZF transgenic mice have diminished numbers of NKT cells, may come from the observation that stage 1 and stage 2 NKT cells express the highest level of PLZF and down-regulate PLZF expression at stage 3 (30) . Thus, enforced transgenic expression of PLZF may partially block NKT cells at this stage.
Taken together, our study gives insight into transcriptional control mechanisms that regulate conventional versus MP T cell development and suggest that PLZF is an important regulator in this process. Further studies aiming to identify and characterize the genetic program that is induced by PLZF are required to further elucidate these developmental processes.
Materials and Methods
Generation of the PLZF Transgenic Construct. The transgene expression cassette consisted of the Cd4 Locus control region/thymocyte enhancer, the Cd4 proximal enhancer/promoter, and a splicing module from silencer-less Cd4 intron 1 sequences, followed by IRES-GFP-polyA sequences, and was provided by Ichiro Taniuchi (Riken, Yokohama, Japan). The cDNA sequence encoding for PLZF (MGI: 103222; nucleotide 249-2352) was inserted as an EcoRI fragment upstream of the IRES-GFP module.
Generation of PLZF Transgenic Mice. The linearized construct was microinjected into a pronucleus of fertilized C57BL/6N inbred oozytes that were transferred afterward into the oviduct of pseudopregnant foster mothers according to standard protocols for generating transgenic mice (31) . Transgene integrations were identified by PCR of tail DNA with GFP-specific primers. Of several identified transgenic founders, we selected lines C57BL/6N-Tg(Cd4-Zbtb16,GFP)141-143 Biat (lines 1-3 for brevity) based on the GFP expression levels.
Mice. Animals used in this study were bred and maintained in the animal facility of the Medical University of Vienna. Analyzed mice were 6 to 8 weeks of age unless indicated otherwise. All animal experiments were approved by the Federal Ministry for Science and Research.
Flow Cytometric Analysis and Antibodies. The following antibodies were used for the staining: PE-anti-CD62L, PE-anti-CD122, PE-Cy7-anti-CD4, PE-anti-IFN␥, and APC-anti-IL-4 from BD Pharmingen; APC-anti-CD8␣ (53-6.7), APC-anti-CD62L, PE-Cy7-anti-CD44, APC-anti-CD25, APC-anti-NK1.1, PE-anti-CD3e, and Pb-anti-CD3e from eBioscience; and A647-anti-CD3 from Caltag. PBS57-loaded and unloaded CD1d tetramers (conjugated with PE) were obtained from the National Institutes of Health tetramer facility and used according to the instructions. Flow cytometry was performed on LSRII (BD Biosciences) and data analyzed using FlowJo software.
Purification of T Cells and Cell Sorting. CD3 ϩ T cells were isolated by incubating cell suspensions of spleens (in PBS solution supplemented with 2% FCS) with biotinylated anti-CD11b, anti-CD11c, anti-CD45R, anti-Ly-6G, anti-Ter119, and anti-NK antibodies, followed by negative depletion using streptavidin beads (BD Pharmingen) according to the manufacturer's instructions. For the isolation of CD4 ϩ T cells, biotinylated anti-CD8␣ antibodies were added to the depletion antibody mixture. The purity of either CD3 ϩ or CD4 ϩ T cells was assessed by flow cytometry and was routinely Ͼ90%-95%. For cell sorting, CD4 ϩ T cells were incubated with anti-CD4, anti-CD44 and anti-CD62L, and CD4 ϩ T cells subsets were sorted into CD44 lo CD62L ϩ , CD44hiCD62L ϩ , and CD44 hi CD62L Ϫ populations with a FACSAria cell sorter (Becton Dickinson).
Activation of T Cells and Cytokine Measurement.
Purified or FACS-sorted CD4 ϩ T cells (5 ϫ 10 5 ) or T cell subsets (5 ϫ 10 5 ) were stimulated with plate-bound anti-CD3 (1 g/ml) and plate-bound anti-CD28 (3 g/ml) on 48-well plates. CD4 ϩ T cells were grown in 1 ml RPMI1640 Glutamax-I (Invitrogen), supplemented with 10% FCS (Invitrogen), antibiotics, and 2-mercaptoethanol (Invitrogen). The supernatants for cytokine quantification were collected 48 h later. IL-2, IL-4, and IFN␥ cytokine levels were determined by ELISA (BD Pharmingen).
For PMA/ionomycin stimulation, thymocytes or splenocytes were incubated for 5 h with PMA (50 ng/ml) and ionomycin (500 ng/ml) (Sigma) in the presence of GolgiSTOP (BD Biosciences). Surface staining for CD3, CD4, CD8, and CD44 was performed, and subsequently cells were fixed and permeabilized with Cytofix/ Cytoperm solution (BD Pharmingen) and further stained with PE-anti-IFN␥.
Statistical Analysis. All data are expressed as mean Ϯ SEM. Statistical analysis was performed by using a Student t test. The P values were defined as following: *P Ͻ 0.05; ** , P Ͻ 0.01; *** , P Ͻ 0.001; n.s., not significant. Note Added in Proof. While this article was in revision, Savage et al. (32) reported similar data as described in our study. They observed that transgenic expression of PLZF induced CD4SP thymocytes and CD4 ϩ T cells to acquire a CD44 hi phenotype. In addition, Savage et al. reported that PLZF is primarily expressed in CD1d-restricted NKT cells and that PLZF-deficient mice have impaired NKT cell differentiation and effector function (in agreement with ref. 30 ).
